Flunixin meglumine antibody and antigen (hapten, BSA/OVA conjugated)

 Download 

Diagnostic anti-Flunixin meglumine antibodies (anti-Flunixin meglumine) and diagnostic hapten-carrier conjugates BSA-Flunixin meglumine, OVA-Flunixin meglumine, KLH-Flunixin meglumine antigens for Inflammation/autoimmune/inflammatory disease Flunixin meglumine detection in ELISA test, competitive ELISA, Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT.

Go to Inflammation/autoimmune/inflammatory disease diagnostics products collection>>

Product information

Size： 1mg | 10mg | 100mg

Product Description

BSA-Flunixin meglumine

OVA-Flunixin meglumine

Anti-human Flunixin meglumine mouse monoclonal antibody (mAb)

Anti-human Flunixin meglumine human monoclonal antibody (mAb)

Reference

Validation Data

Click to get more Data / Case study about the product.

Target/Biomarker information

1. Flunixin Meglumine: Its Significance in In Vitro Diagnosis (IVD)

Flunixin Meglumine, a non-steroidal anti-inflammatory drug (NSAID), holds a crucial and multifaceted role in the domain of in vitro diagnosis (IVD), particularly within the purview of veterinary medicine. Its emergence as a fundamental component in diagnostic applications stems from its remarkable attributes as a reference compound or calibration standard. In the intricate landscape of diagnostic assays, Flunixin Meglumine serves as the linchpin, responsible for establishing a foundational baseline response or concentration. This calibration process is pivotal for ensuring the precision, accuracy, and reliability of various diagnostic tests and assays that are indispensable in veterinary diagnostics.

2. The Imperative of Measuring Flunixin Meglumine

The measurement of Flunixin Meglumine holds profound and multifarious significance, extending across several domains:

Quality Control: Flunixin Meglumine stands as an embodiment of quality control in diagnostic tests. Its role is nothing short of indispensable, as it meticulously scrutinizes the integrity and functionality of diagnostic assays. By subjecting these assays to the discerning eye of Flunixin Meglumine, the scientific and clinical community ensures that every facet of the test, from reagents to instrumentation, is performing optimally. This stringent quality control process is an assurance of accurate and precise results, which form the bedrock of diagnostic decision-making.

Assay Validation: In the intricate and meticulous development phases of diagnostic assays, Flunixin Meglumine steps into the spotlight as a reference compound of known concentration. This step is critical in the journey from assay conception to its practical application. Flunixin Meglumine is tasked with the role of validating the performance characteristics of the assay, ranging from accuracy to precision and linearity. The validation process ensures that the assay is indeed ready for deployment in real-world clinical or research scenarios. It instills confidence in the assay's ability to deliver consistent, trustworthy results across the spectrum of potential diagnostic applications.

Research and Pharmacokinetics: Beyond the confines of diagnostic assays, Flunixin Meglumine assumes an equally significant role in research settings. Here, its measurement serves as a compass, guiding scientists and researchers through the intricate terrain of pharmacokinetics, distribution patterns, and elimination pathways within animal models. The insights gleaned from these investigations are instrumental in optimizing therapeutic protocols and refining treatment regimens. By understanding how Flunixin Meglumine behaves within the biological milieu, researchers can fine-tune dosages and administration schedules, thereby enhancing the efficacy and safety of NSAID treatments.

Safety and Residue Monitoring: In the realm of veterinary medicine, the meticulous measurement of Flunixin Meglumine extends its reach into the domain of food safety and regulatory compliance. Ensuring that animal-derived products, such as meat and milk, are free from harmful residues of veterinary drugs is an absolute imperative. Flunixin Meglumine serves as the sentinel in this quest for safety, with precise measurement methodologies at its disposal. Through these methodologies, potential residues of Flunixin Meglumine are detected and quantified, thus safeguarding consumer safety and adhering to stringent regulatory standards.

In summation, the measurement of Flunixin Meglumine is not a mere technicality but rather the lynchpin of precision and quality within the realm of in vitro diagnosis (IVD). Its role as a calibration standard and its multifaceted contributions to quality control, assay validation, research, and safety monitoring underscore its importance in the multifaceted world of veterinary medicine and diagnostics. Flunixin Meglumine ensures that diagnostic tests are reliable, research is precise, and the food supply remains safe, ultimately benefiting the well-being of animals and the assurance of public health.

About GDU